Chemotherapy Infusion Pumps Market Analysis, Demand And Outlook 2025- 2034
Save 20% on All Global Market Reports With Code ONLINE20 – Gain Insights Into Tariffs, Inflation, and Industry Trends
What Is the Potential Market Growth Rate of the Chemotherapy Infusion Pumps Market?
The chemotherapy infusion pumps market size has grown strongly in recent years. It will grow from $4.92 billion in 2024 to $5.2 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to shift to outpatient care, cancer incidence, healthcare infrastructure development, aging population, and healthcare expenditure.
The chemotherapy infusion pumps market size is expected to see strong growth in the next few years. It will grow to $6.56 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to home healthcare expansion¸ increasing cancer incidence, awareness and screening programs, favorable regulatory policies, and faster approval processes for new medical devices. Major trends in the forecast period include integration of smart technologies, home-based chemotherapy treatments, emphasis on pumps with advanced safety features, customization and precision infusion pumps, and enhanced integration with EHR systems.
Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18534&type=smp
What Are the Primary Growth Contributors in the Chemotherapy Infusion Pumps Market?
The increasing incidence of cancer is expected to propel the growth of the chemotherapy infusion pumps market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer is fueled by factors such as lifestyle modifications, inherited genetic predispositions, and a combination of genetic mutations and environmental factors, such as smoking, radiation, chemicals, and infectious agents. Chemotherapy infusion pumps aid cancer patients by delivering precise, continuous doses of chemotherapy drugs, optimizing drug administration, and minimizing side effects. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing cancer incidence will drive the chemotherapy infusion pump market.
What Are the Major Product/Service Segments in the Chemotherapy Infusion Pumps Market?
The chemotherapy infusion pumpsmarket covered in this report is segmented –
1) By Type: Large Volume Pumps, Syringe Pump, Elastomeric Pumps, Ambulatory Infusion Pumps, Other Types
2) By Usage: Disposable, Reusable
3) By End User: Hospitals, Clinics, Home Care, Other End Users
Subsegments
1) By Large Volume Pumps: Traditional Large Volume Pumps, Volumetric Infusion Pumps
2) By Syringe Pump: Manual Syringe Pumps, Electronic Syringe Pumps
3) By Elastomeric Pumps: Disposable Elastomeric Pumps, Reusable Elastomeric Pumps
4) By Ambulatory Infusion Pumps: Disposable Ambulatory Infusion Pumps, Reusable Ambulatory Infusion Pumps
5) By Other Types: Smart Infusion Pumps, Patient-Controlled Analgesia (Pca) Pumps
Which Trends Are Positively Affecting the Chemotherapy Infusion Pumps Market Expansion?
Major companies operating in the chemotherapy infusion pumps market are innovating advanced technologies, such as customizable infusion rates for multiple chemotherapy drugs, to enable more personalized and precise treatment plans. Customizable infusion rates for chemotherapy infusion pumps allow healthcare providers to adjust the speed and dosage of chemotherapy drug delivery according to each patient's specific requirements. For instance, in May 2023, Mindray, a China-based medical device and solution provider, introduced an innovative infusion mode called 'Rhythm Dose' in their latest BeneFusion i/u infusion pump series. This advanced feature is specifically designed to optimize the delivery of chemotherapy drugs. It allows healthcare professionals to administer continuous intravenous infusions of multiple chemotherapy drugs at varying rates, facilitating more personalized treatment plans.
Who Are the Prominent Players in theChemotherapy Infusion Pumps Market?
Major companies operating in the chemotherapy infusion pumps market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Smiths Group plc, Moog Inc., Avanos Medical Inc., Halyard Health, Vygon SAS, Palex Medical SA, Samtronic SA, ICU Medical Inc., Pfm Medical Ag, Zyno Medical LLC, Leventon S.A.U., InfuTronix Solutions LLC, Heka Healthcare, PROMECON GmbH
Get the full chemotherapy infusion pumps market report here:
https://www.thebusinessresearchcompany.com/report/chemotherapy-infusion-pumps-global-market-report
What Are the Opportunities and Challenges for Chemotherapy Infusion Pumps Market Across Regions?
North America was the largest region in the chemotherapy infusion pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment